Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease.
about
Health effects of dietary phospholipidsMarine omega-3 phospholipids: metabolism and biological activities.Krill products: an overview of animal studiesCombined effect of sesamin and soybean phospholipid on hepatic fatty acid metabolism in rats.Human Stem Cell-Derived Endothelial-Hepatic Platform for Efficacy Testing of Vascular-Protective Metabolites from Nutraceuticals.C57Bl/6 N mice on a western diet display reduced intestinal and hepatic cholesterol levels despite a plasma hypercholesterolemiaHepatic accumulation of intestinal cholesterol is decreased and fecal cholesterol excretion is increased in mice fed a high-fat diet supplemented with milk phospholipids.Optimized rapeseed oils rich in endogenous micronutrients ameliorate risk factors of atherosclerosis in high fat diet fed rats.Hydrophilic interaction chromatography based solid-phase extraction and MALDI TOF mass spectrometry for revealing the influence of Pseudomonas fluorescens on phospholipids in salmon fillet.Krill oil attenuates left ventricular dilatation after myocardial infarction in rats.Lipid Fingerprinting in Mild versus Severe Forms of Gestational Diabetes MellitusFish oil and krill oil differentially modify the liver and brain lipidome when fed to mice.Dietary sea cucumber cerebroside alleviates orotic acid-induced excess hepatic adipopexis in rats.Effects of dietary milk- and soya-phospholipids on lipid-parameters and other risk indicators for cardiovascular diseases in overweight or obese men - two double-blind, randomised, controlled, clinical trials.Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice.Nutritional properties of dietary omega-3-enriched phospholipids.Formulation and shelf life stability of water-borne lecithin nanoparticles for potential application in dietary supplements field.Dietary phosphatidylinositol protects C57BL/6 mice from concanavalin A-induced liver injury by modulating immune cell functions.Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease.Dietary phospholipids and intestinal cholesterol absorption.Genotoxicity test and subchronic toxicity study with Superba™ krill oil in rats.Natural phospholipids: Occurrence, biosynthesis, separation, identification, and beneficial health aspects.Identification of biomarkers for unstable angina by plasma metabolomic profiling.Regulation of hepatic lipid deposition by phospholipid in large yellow croaker.Effect of soy lecithin on fatigue and menopausal symptoms in middle-aged women: a randomized, double-blind, placebo-controlled study.Improving effect of dietary soybean phospholipids supplement on hepatic and serum indexes relevant to fatty liver hemorrhagic syndrome in laying hens.Navy Bean and Rice Bran Intake Alters the Plasma Metabolome of Children at Risk for Cardiovascular Disease.Antioxidant and hepatoprotective effects of mixed micellar lipid formulation of phyllanthin and piperine in carbon tetrachloride-induced liver injury in rodents.The effects of glucose and lipids in steatotic and non-steatotic livers in conditions of partial hepatectomy under ischaemia-reperfusion
P2860
Q27025184-E211982A-B18C-4795-893F-0F3E9807BE01Q27690878-97F77610-F182-40A3-80DC-C85D09C3DA76Q28081951-58963394-37E1-4F24-A4E7-E074FB5073D5Q33701700-33D9308E-3B5A-4AD2-8F2D-258E6D86E1DCQ33722328-59CE5589-1075-498E-B12E-A85C7FE8E514Q34186425-409395E1-C188-436E-85D4-9BAA5141ACB1Q34506779-B683AC76-675F-4F3C-A43C-214685398CB7Q34515284-A0CC19D3-DF8A-42B1-9DD0-3BF58DEBB402Q35506079-FBD173F5-BDAE-402B-997E-8A748F936D65Q35761506-F9891A67-905C-4FE2-8658-4B9EFB1C36EDQ35860169-24191618-5BA8-4210-98EC-32EC56560B3AQ35938274-79DCC6CD-3CBB-4020-83B6-FA9B0E19E6CEQ36335120-681A582C-136B-45C1-B84D-FE453A95FCE1Q36964496-EF76D0D2-565F-48EC-87DD-18C9F2EAF02EQ37056912-EDCF843A-17E5-458F-B3C3-BA65A8D021E1Q37105403-3FC26A2D-D25E-4206-BF04-7209D820F555Q38034567-C9F698C1-90E9-4D28-8AD5-489B6EDB0298Q39094136-AF22BC03-6BCD-45FC-AC45-A60B9D8FB261Q39224276-368C66F7-3109-4C81-AF6A-EEFDCCE96DBDQ40378508-CBC27A6A-8D22-447C-A9CD-652209CA67A4Q41681103-FCDC1C51-D62F-432A-8147-FB72E99EF3C7Q46613052-CDB925CB-F4EF-4323-BBFB-CC06F14E8906Q46959632-914CF05B-8F9C-4702-A333-D9EADB035E5EQ47337920-CC3ED072-174D-437E-A8DB-859A2DF6D8A3Q47647861-CB9A4B4A-A156-4D5A-A497-6054CBDF2700Q48058445-928D333A-5B40-4744-B851-4BE0556F8813Q50195561-DF58032B-8821-4C3F-800A-5F611482B94CQ51786459-F795723A-C64E-4579-8235-8C72347FDDDAQ56797094-F17D21B8-5685-441F-9159-DE9122DA5B54
P2860
Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease.
@en
Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease.
@nl
type
label
Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease.
@en
Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease.
@nl
prefLabel
Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease.
@en
Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease.
@nl
P2093
P1476
Dietary phospholipids, hepatic lipid metabolism and cardiovascular disease.
@en
P2093
Alvin Kamili
Elaine Wat
Jeffrey S Cohn
Sally Tandy
P304
P356
10.1097/MOL.0B013E3282FFAF96
P577
2008-06-01T00:00:00Z